KD-Validated MYC Recombinant Rabbit Monoclonal Antibody

KD-Validated MYC Recombinant Rabbit Monoclonal Antibody

Cat. No.: KVAb01724
Size:20μL Price:$118
Size:50μL Price:$218
Size:100μL Price:$318
Application:WB,FCM,ICC,IHC-P

Reactivity:Human,Mouse
Conjugate:Unconjugated
Gene Name:MYC
Category: KO&KD Validated Antibodies Tags: , , , , , , , , , , , ,

Summary

Production Name

KD-Validated MYC Recombinant Rabbit Monoclonal Antibody

Description

KD-Validated antibody

Host

Rabbit

Application

WB,FCM,ICC,IHC-P

Reactivity

Human,Mouse

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

Rabbit IgG

Clonality

Rabbit mAb

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.

Purification

Affinity purification

 

Immunogen

Gene Name

MYC

Alternative Names

MYC; MYC Proto-Oncogene, BHLH Transcription Factor; BHLHe39; C-Myc; MYCC; V-Myc Avian Myelocytomatosis Viral Oncogene Homolog; Class E Basic Helix-Loop-Helix Protein 39; Myc Proto-Oncogene Protein; Transcription Factor P64; Proto-Oncogene C-Myc; Myc-Related Translation/Localization Regulatory Factor; Avian Myelocytomatosis Viral Oncogene Homolog; V-Myc Myelocytomatosis Viral Oncogene Homolog; BHLHE39; MRTL

Gene ID

4609

SwissProt ID

P01106

 

Application

Dilution Ratio

WB 1:1,000-1:5,000; FC 1:200-1:2,000; ICC 1:100-1:1,000; IHC-P 1:100-1:200

Molecular Weight

Calculated MW: 48.8kDa

 

Background

This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017]

 

Research Area

Epigenetics and Nuclear Signaling,Stem Cells,Cancer,Signal Transduction

   💬 WhatsApp